1. ALLA AKTIER
  2. NYHETER
  3. STILLE

Stille

Nyheter Stille Nyheter alla bolag

Stille AB appoints Ulrik Berthelsen as Chief Executive Officer

MAR

Torshälla, Sweden – 9 May 2025 – The Board of Directors of Stille AB (“Stille”), a leading provider of premium surgical instruments and advanced surgical tables for high-precision procedures, is pleased to announce the appointment of Ulrik Berthelsen as its new Chief Executive Officer, effective 12 May 2025.

With a distinguished background in the medical technology sector and a proven track record of strategic leadership and of driving growth organically as well as through M&A in both US and European markets, Mr. Berthelsen brings a wealth of experience to Stille. He succeeds Torbjörn Sköld, who has been the Chief Executive Officer since 20 Mar 2023.

Over the past 20 years, Ulrik Berthelsen has held senior international positions, primarily at Coloplast and Atos Medical, where he has led transformative initiatives delivering strong growth and innovation. His appointment marks an exciting new chapter for Stille, as the company continues to expand its global presence and reinforce its commitment to surgical precision and patient care.

"We are thrilled to welcome Ulrik to Stille," said Jón Sigurdsson, recently appointed Chairman of the Board of Directors and former long-time CEO of Össur/Embla Medical. "His deep industry knowledge, visionary leadership, and customer-focused approach will be instrumental in driving the next phase of our growth and innovation."

Mr. Berthelsen commented: “I am honored to join Stille, a company with a remarkable heritage and strong reputation for quality and innovation. I look forward to working with the team at Stille to build on this foundation and accelerate our progress in delivering value to surgeons and patients worldwide.”

The Board of Directors expresses its sincere gratitude to Torbjörn Sköld for his contributions to the company over the past two years.

This information is information that Stille is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2025-05-09 08:00 CEST.

Contact Details
Jón Sigurdsson
Chairman of the Board
+35 (0) 466 41 02 | jon@emblamedical.com 

About Us
Stille AB (publ) develops, manufactures and markets medical devices for surgeons across the world. Stille was founded in 1841 and is one of the world’s oldest medical device companies. Stille’s main business areas are surgical instruments and c-arm tables. Stille’s surgical instruments are mostly used during different kinds of open surgery. During minimal invasive procedures. the c-arm tables imagiQ2 and Medstone are key products. The company has a strong brand and products of a renowned high-quality. The share is listed on First North Growth Market under the acronym “STIL” with Eminova AB as Certified Adviser, Eminova Fondkommission AB, + 46 8 684 211 10, adviser@eminova.se. For more information, visit www.stille.se.

Attachments
Stille AB appoints Ulrik Berthelsen as Chief Executive Officer

Datum 2025-05-09, kl 08:00
Källa MFN
Bifogade filer
Stille AB appoints Ulrik Berthelsen as Chief Executive Officer
Affiliate
Skapa konto direkt med BankID hos Skilling så får du tillgång till tusentals finansmarknader inom valuta, aktier, krypto och mycket mer. Välj bland 1200+ CFD-instrument över 7 tillgångsklasser till konkurrenskraftiga priser. Skilling erbjuder också en kapitalförsäkring.
CFD är komplexa instrument och har en hög risk att förlora pengar snabbt på grund av hävstång. 77% av icke-professionella kunder förlorar pengar när de handlar med CFD med denna leverantör.